Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Investigation launched into medicinal cannabis doctors following patient suicide

Published 11/10/2024, 12:30 pm
Updated 11/10/2024, 01:00 pm
© Reuters.  Investigation launched into medicinal cannabis doctors following patient suicide

The pharmacist who founded Australia’s first subscription-based medicinal cannabis platform, Dispensed, has been banned from supplying cannabis and a further two doctors have been suspended as authorities launch an investigation into a man's death, and alleged inappropriate prescribing to another patient.

The New South Wales coroner is preparing a report into the death of the 41-year-old, who had a pre-existing mental health condition exacerbated by medicinal cannabis prescribed through Dispensed.

Despite his history of hallucinations and psychosis, the deceased received continued cannabis deliveries after his death was reported to the platform by his family.

According to Professor Brett Emmerson, chair of the Queensland branch of the Royal Australian and New Zealand College of Psychiatrists, it is inappropriate to prescribe medicinal cannabis to any patient with a history of psychosis or schizophrenia.

Emmerson said, "One of the most common causes, over many years as a psychiatrist, of people (with schizophrenia) relapsing is the fact that they get their hands on THC.”

The father of the deceased man expressed dismay over the ease with which cannabis was prescribed, circumventing his son’s regular medical providers.

In a separate incident, as revealed by an ABC investigation, a 31-year old patient diagnosed with schizophrenia received cannabis despite warnings from his mother. This led to a severe deterioration in mental health, culminating in hospitalisation under involuntary treatment.

Concerns have been raised over the regulatory oversight of telehealth platforms like Dispensed, where prescriptions are issued remotely without adequate checks.

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.